Pliant Therapeutics, Inc. (PLRX) stock

PLRXNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30

$0.70−0.04 (-5.81%)

Close on Nov 13, 2026Market cap $43.16MP/E –Yield 0.00%

Pliant Therapeutics EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Pliant Therapeutics's EV/EBITDA was 29.5× on Jan 29, 2021.

Period	Period end	Value	Change (pts)
2021	Jan 29, 2021	29.5×	+3.4
2020	Dec 31, 2020	26.1×	–

Parsed from the XBRL in Pliant Therapeutics's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is PLRX.

Advertisement
300 × 250

See a number that looks wrong?